Skip to content
Search

Latest Stories

Numark announces largest own-label OTC range in pharmacy wholesale

Numark continues to expand its own-label OTC range

In addition to expanding its own label product range, Numark has re-designed its product packaging to modernize the brand look

Numark continues to expand its own-label OTC range as more and more customers seek affordable, trusted alternatives to branded products, driven by the cost-of-living crisis.

The organisation has announced that it now offers the largest own label OTC range in the UK pharmacy wholesale market, available to independent pharmacy, with almost 300 products across multiple categories.


In addition to growing its product offering, Numark has undertaken a full packaging re-design of all products to modernize the brand’s look while enhancing consumer choice and value.

Numark's own label range includes common OTC medicines like paracetamol, ibuprofen, loperamide and treatments for common ailments such as coughs, colds and allergies. They also offer a comprehensive range of vitamins, baby products, footcare, personal care, and health and beauty accessories.

Jennifer Rann, head of OTC at Numark said: “We are incredibly proud to be the largest own label OTC offering in pharmacy wholesale. Our Numark product range provides quality and value for our UK members and their customers.”

She also highlighted Numark’s ongoing efforts to research the OTC market and explore new product development opportunities to further expand their range, providing even more value to both its members and customers.

The Numark own label range is available exclusively to Numark members.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less